Thomas E. Cataldo

Harvard University, Beth Israel Deaconess Medical Center

Papers

Total Citations

H-Index

About

Thomas E. Cataldo is a colorectal surgeon whose research navigates the intersection of surgical innovation, cost-effectiveness, and oncologic outcomes. His work spans the technical frontiers of robotic surgery—most notably with his 2018 study on the robotic excision of retrorectal masses (7 citations)—while also critically examining the financial footprint of surgical decision-making. In a field often focused solely on technique, Cataldo’s 2017 analysis of surgeon-driven costs in minimally invasive colectomy (5 citations) challenges practitioners to reconsider their role in healthcare economics, arguing that individual choices may matter less than assumed. More recently, his 2023 investigation into neoadjuvant chemotherapy for locally advanced colon cancer (5 citations) addresses a pressing clinical question: whether preoperative treatment increases postoperative complications. By pairing rigorous outcomes research with a pragmatic eye on resource utilization, Cataldo contributes to a more holistic understanding of modern colorectal surgery—one that values both patient safety and systemic sustainability. His work offers valuable insights for surgeons and trainees navigating an era of heightened accountability.